The Integrated Technology Resource for Biomedical Glycomics at the University of Georgia is focused on developing technologies and tools for the biomedical community to facilitate the study of glycomics: the glycans, glycoconjugates, proteins that regulate their expression, and proteins that recognize them. The platform the Resource has chosen to drive glycomics technology development is that of stem cell differentiation in vitro. One of the most promising areas of biomedical research is in the differentiation of stem cells into cell types that can be developed for the treatment of various diseases, such as diabetes. As differentiation is directed in culture, there is a critical need for the development of specific cell surface markers to enable separation of target cell populations. Since cells are covered with glycans, and glycan expression is known to change during differentiation and in many diseases such as cancer, they are prime targets for cell marker discovery. The technologies of the Resource have allowed significant progress in identifying specific changes in cellular glycan expression during mouse stem cell differentiation. During the next funding cycle, the Resource will transition into human stem cells, both embryonic and adult. Through its own Core 1 Human Stem Cell Platform and Collaborative Projects, several types of cells will be analyzed. Core 2, Glycoprotein and Glycolipid Analysis, will focus on increasing the sensitivities of glycan identification and quantitation such that <105 cells can be analyzed, opening the door for the use of clinical tissue samples. In addition, this Core will also focus on methods for elucidating the site-specific glycosylation of glycoproteins, a novel method for studying glycan biosynthesis using metabolic isotopic labeling of glycans, and glycosphingolipid expression. Core 3, Glycotranscriptome, will continue to develop methods for RTPCR quantitation of glycogene transcripts (mouse and human) and elucidating glycan biosynthetic pathways. Core 4, Bioinformatics, will extend its programs to allow integration of glycan and transcript expression to allow a comprehensive picture of the changes of the glycome during differentiation and means to visualize and query the data. In addition, it will expand its CLYDE II protocol that allows various carbohydrate databases from around the world to communicate. The Analytical Service and Training Program of the Resource analyzes samples from across the U.S., has added glycotranscriptome analysis, and is expanding to include glycosaminoglycans analysis. Several workshops on various aspects of glycan analysis are offered each year. Technologies from the Resource are having an impact on stem cell medicine, as well as the development of biomarkers for specific types of cancer and for other diseases such as Type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
8P41GM103490-10
Application #
8300222
Study Section
Special Emphasis Panel (ZRG1-CB-L (40))
Program Officer
Sheeley, Douglas
Project Start
2003-09-01
Project End
2013-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
10
Fiscal Year
2012
Total Cost
$1,686,251
Indirect Cost
$600,117
Name
University of Georgia
Department
Type
Organized Research Units
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Talabnin, Krajang; Talabnin, Chutima; Ishihara, Mayumi et al. (2016) Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines. Asian Pac J Cancer Prev 17:691-5
Yu, Seok-Ho; Zhao, Peng; Sun, Tiantian et al. (2016) Selective Exo-Enzymatic Labeling Detects Increased Cell Surface Sialoglycoprotein Expression upon Megakaryocytic Differentiation. J Biol Chem 291:3982-9
Parkinson, William M; Dookwah, Michelle; Dear, Mary Lynn et al. (2016) Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model. Dis Model Mech 9:513-27
Berger, Ryan P; Dookwah, Michelle; Steet, Richard et al. (2016) Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders. Bioessays 38:1255-1265
Deligny, Audrey; Dierker, Tabea; Dagälv, Anders et al. (2016) NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length. J Biol Chem 291:18600-7
Durning, Sean P; Flanagan-Steet, Heather; Prasad, Nripesh et al. (2016) O-Linked β-N-acetylglucosamine (O-GlcNAc) Acts as a Glucose Sensor to Epigenetically Regulate the Insulin Gene in Pancreatic Beta Cells. J Biol Chem 291:2107-18
Sanda, Miloslav; Benicky, Julius; Wu, Jing et al. (2016) Increased sialylation of site specific O-glycoforms of hemopexin in liver disease. Clin Proteomics 13:24
LaMattina, Joseph W; Nix, David B; Lanzilotta, William Nicholas (2016) Radical new paradigm for heme degradation in Escherichia coli O157:H7. Proc Natl Acad Sci U S A 113:12138-12143
Hildebrandt, Emily R; Cheng, Michael; Zhao, Peng et al. (2016) A shunt pathway limits the CaaX processing of Hsp40 Ydj1p and regulates Ydj1p-dependent phenotypes. Elife 5:
Aoki-Kinoshita, Kiyoko; Agravat, Sanjay; Aoki, Nobuyuki P et al. (2016) GlyTouCan 1.0 - The international glycan structure repository. Nucleic Acids Res 44:D1237-42

Showing the most recent 10 out of 76 publications